DAA use decreases risk for cardiovascular events in patients with advanced fibrosis, HCV

LONDON — Direct-acting antiviral treatment correlated with a decreased risk for cardiovascular outcomes among patients with hepatitis C virus and advanced fibrosis but an increased risk for arrhythmias and conduction disorders.“Several studies have revealed that hepatitis C virus can induce chronic inflammation and immune dysregulation, and this immune dysregulation and chronic inflammation explained the development…

NAFLD, alcohol-associated liver disease spurs rise in global liver cancer deaths

LONDON — Nonalcoholic fatty liver disease and alcohol-associated liver disease are among the main contributors of increased mortality related to chronic liver disease and liver cancer burden, according to research.“Although viral hepatitis B and C and alcohol liver disease have historically been the drivers of burden of chronic liver disease and liver cancer, NAFLD and…

Low-carbohydrate, high-fat diet reduced fatty liver, improved type 2 diabetes control

LONDON — A low-carbohydrate, high-fat diet significantly improved nonalcoholic fatty liver disease activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with type 2 diabetes mellitus, according to a researcher here.“If you have fat in the liver, you will benefit from eating fat,” Camilla Dalby Hansen, MD, from Odense University Hospital in…

Female prisons ‘main reservoir’ for hepatitis C, key target for elimination initiatives

LONDON — A high intensity test and treat initiative for hepatitis C elimination in England proved to be beneficial for testing and treating incarcerated individuals, according to results at the International Liver Congress.“The [National Health Service] hepatitis C elimination program is working toward a shared goal of eliminating hepatitis C as a public health issue,…